• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

叉头框蛋白 A 家族在人肺癌中的表达与预后分析。

Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.

机构信息

Department of Gastrointestinal Surgery, Zhongnan Hospital of Wuhan University, PR China; Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, 430071 Wuhan, Hubei, PR China.

Department of Thyroid and Breast Surgery, Zhongnan Hospital of Wuhan University, PR China.

出版信息

Gene. 2019 Feb 15;685:202-210. doi: 10.1016/j.gene.2018.11.022. Epub 2018 Nov 9.

DOI:10.1016/j.gene.2018.11.022
PMID:30415009
Abstract

Despite advances in early diagnosis and treatment, cancer still remains the major reason of mortality worldwide. The forkhead box A (FOXA) family is reported to participate in diverse human diseases. However, little is known about their expression and prognostic values in human lung cancer. Herein, we conducted a detailed cancer vs. normal analysis. The mRNA expression levels of FOXA family in numerous kind of cancers, including lung cancer, were analyzed using the Oncomine and GEPIA database. We observed that the mRNA expression levels of FOXA1, and FOXA3 were all increased while FOXA2 were decreased in most cancers compared with normal tissues, especially in lung cancer. Moreover, the expression levels of FOXA1, and FOXA3 are also highly expressed, while FOXA2 were decreased in almost all cancer cell lines, particularly in lung cancer cell lines, analyzing by Cancer Cell Line Encyclopedia (CCLE) and EMBL-EBI databases. Furthermore, the LinkedOmics database was used to evaluate the prognostic values, indicating that higher expression of FOXA1, FOXA3 indicated a poor overall survival (OS), while increased FOXA2 revealed a better OS in lung cancer. To conclusion, FOXA family showed significant expression differences between cancer and normal tissues, especially lung cancer, and FOXA1, FOXA3 could be promising prognostic biomarkers for lung cancer.

摘要

尽管在早期诊断和治疗方面取得了进展,但癌症仍然是全球主要的死亡原因。叉头框 A(FOXA)家族被报道参与多种人类疾病。然而,它们在人类肺癌中的表达和预后价值知之甚少。在此,我们进行了详细的癌症与正常组织分析。使用 Oncomine 和 GEPIA 数据库分析了 FOXA 家族在包括肺癌在内的多种癌症中的 mRNA 表达水平。我们观察到,与正常组织相比,FOXA1 和 FOXA3 的 mRNA 表达水平在大多数癌症中均升高,而 FOXA2 则降低,尤其是在肺癌中。此外,通过 Cancer Cell Line Encyclopedia (CCLE) 和 EMBL-EBI 数据库分析,FOXA1 和 FOXA3 的表达水平也高度表达,而 FOXA2 在几乎所有癌细胞系中均降低,尤其是在肺癌细胞系中。此外,使用 LinkedOmics 数据库评估了预后价值,表明 FOXA1 和 FOXA3 的高表达预示着肺癌的总体生存率(OS)较差,而 FOXA2 的增加则预示着肺癌的 OS 较好。总之,FOXA 家族在癌症与正常组织之间表现出显著的表达差异,尤其是在肺癌中,FOXA1 和 FOXA3 可能是肺癌有前途的预后生物标志物。

相似文献

1
Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer.叉头框蛋白 A 家族在人肺癌中的表达与预后分析。
Gene. 2019 Feb 15;685:202-210. doi: 10.1016/j.gene.2018.11.022. Epub 2018 Nov 9.
2
Opposing Roles of FoxA1 and FoxA3 in Intrahepatic Cholangiocarcinoma Progression.FoxA1 和 FoxA3 在肝内胆管癌进展中的相反作用。
Int J Mol Sci. 2020 Mar 5;21(5):1796. doi: 10.3390/ijms21051796.
3
Protein or amino acid deprivation differentially regulates the hepatic forkhead box protein A (FOXA) genes through an activating transcription factor-4-independent pathway.蛋白质或氨基酸缺乏通过一条不依赖于激活转录因子4的途径对肝脏叉头框蛋白A(FOXA)基因进行差异性调控。
Hepatology. 2009 Jul;50(1):282-90. doi: 10.1002/hep.22971.
4
Differential binding and co-binding pattern of FOXA1 and FOXA3 and their relation to H3K4me3 in HepG2 cells revealed by ChIP-seq.通过 ChIP-seq 揭示 FOXA1 和 FOXA3 的差异结合和共结合模式及其与 HepG2 细胞中 H3K4me3 的关系。
Genome Biol. 2009;10(11):R129. doi: 10.1186/gb-2009-10-11-r129. Epub 2009 Nov 17.
5
Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia.人类白血病中 runt 相关转录因子家族的表达及预后分析
Mol Ther Oncolytics. 2018 Dec 18;12:103-111. doi: 10.1016/j.omto.2018.12.008. eCollection 2019 Mar 29.
6
Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.上调的叉头框A3提高叉头框A1和叉头框A2的表达以促进食管癌转移。
Oncol Lett. 2019 May;17(5):4351-4360. doi: 10.3892/ol.2019.10078. Epub 2019 Feb 26.
7
The Foxa family of transcription factors in development and metabolism.发育与代谢过程中的叉头框A转录因子家族
Cell Mol Life Sci. 2006 Oct;63(19-20):2317-28. doi: 10.1007/s00018-006-6095-6.
8
The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH.肺腺癌中FoxA1与FoxA2的比例受长链非编码RNA HOTAIR和染色质重塑因子LSH调控。
Sci Rep. 2015 Dec 11;5:17826. doi: 10.1038/srep17826.
9
The transcriptional regulation of SOX2 on FOXA1 gene and its application in diagnosis of human breast and lung cancers.SOX2对FOXA1基因的转录调控及其在人类乳腺癌和肺癌诊断中的应用。
Clin Lab. 2014;60(6):909-18. doi: 10.7754/clin.lab.2013.130437.
10
FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.FoxA1 和 FoxA2 驱动胃分化并抑制 NKX2-1 阴性肺癌中的鳞状表型。
Elife. 2018 Nov 26;7:e38579. doi: 10.7554/eLife.38579.

引用本文的文献

1
Novel Therapeutic Target for ALI/ARDS: Forkhead Box Transcription Factors.新型急性肺损伤/急性呼吸窘迫综合征治疗靶点:叉头框转录因子。
Lung. 2024 Oct;202(5):513-522. doi: 10.1007/s00408-024-00740-z. Epub 2024 Sep 11.
2
FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma.FOXA3 通过调节胆固醇代谢来补偿肺腺癌进展过程中的摄取减少。
PLoS Biol. 2024 May 28;22(5):e3002621. doi: 10.1371/journal.pbio.3002621. eCollection 2024 May.
3
Identification of ITGB4 as a novel tumor promoting gene in lung adenocarcinoma (LUAD).
鉴定 ITGB4 为肺腺癌(LUAD)中的一个新的肿瘤促进基因。
Oncol Rep. 2024 Feb;51(2). doi: 10.3892/or.2023.8689. Epub 2023 Dec 22.
4
HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome.HOXC10通过靶向FOXA3促进食管鳞状细胞癌进展,并提示生存预后不良。
Heliyon. 2023 Oct 14;9(10):e21056. doi: 10.1016/j.heliyon.2023.e21056. eCollection 2023 Oct.
5
FOXA2 and STAT5A regulate oncogenic activity of KIF5B-RET fusion.FOXA2和STAT5A调节KIF5B-RET融合蛋白的致癌活性。
Am J Cancer Res. 2023 Feb 15;13(2):638-653. eCollection 2023.
6
Transformer for Gene Expression Modeling (T-GEM): An Interpretable Deep Learning Model for Gene Expression-Based Phenotype Predictions.用于基因表达建模的Transformer(T-GEM):一种用于基于基因表达的表型预测的可解释深度学习模型。
Cancers (Basel). 2022 Sep 29;14(19):4763. doi: 10.3390/cancers14194763.
7
Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.非编码 RNA 相关竞争性内源 RNA 调控网络:肝细胞癌的新诊断和治疗机会。
J Cell Mol Med. 2022 Jan;26(2):287-305. doi: 10.1111/jcmm.17126. Epub 2021 Dec 14.
8
Inhibiting roles of FOXA2 in liver cancer cell migration and invasion by transcriptionally suppressing microRNA-103a-3p and activating the GREM2/LATS2/YAP axis.FOXA2通过转录抑制微小RNA-103a-3p并激活GREM2/LATS2/YAP轴对肝癌细胞迁移和侵袭的抑制作用
Cytotechnology. 2021 Aug;73(4):523-537. doi: 10.1007/s10616-021-00475-2. Epub 2021 May 26.
9
Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis.转录因子:细胞发育与癌变之间的支点
Front Oncol. 2021 Jun 14;11:681377. doi: 10.3389/fonc.2021.681377. eCollection 2021.
10
m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance.m6A RNA 甲基化介导的 HNF3γ 减少导致肝细胞癌去分化和索拉非尼耐药。
Signal Transduct Target Ther. 2020 Dec 26;5(1):296. doi: 10.1038/s41392-020-00299-0.